Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $4.58 in the last session, down -7.47% from day before closing price of $4.95. In other words, the price has decreased by -$7.47 from its previous closing price. On the day, 1.38 million shares were traded. MRVI stock price reached its highest trading level at $4.98 during the session, while it also had its lowest trading level at $4.56.
Ratios:
We take a closer look at MRVI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.
On December 05, 2024, Goldman Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $4.25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1158851072 and an Enterprise Value of 952816256. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.18 while its Price-to-Book (P/B) ratio in mrq is 1.88. Its current Enterprise Value per Revenue stands at 3.441 whereas that against EBITDA is 919.707.
Stock Price History:
The Beta on a monthly basis for MRVI is -0.08, which has changed by -0.16727275 over the last 52 weeks, in comparison to a change of 0.19995654 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is -14.42%, while the 200-Day Moving Average is calculated to be -39.26%.
Shares Statistics:
According to the various share statistics, MRVI traded on average about 2.09M shares per day over the past 3-months and 1791180 shares per day over the past 10 days. A total of 141.59M shares are outstanding, with a floating share count of 117.88M. Insiders hold about 16.90% of the company’s shares, while institutions hold 87.32% stake in the company. Shares short for MRVI as of 1736899200 were 8918685 with a Short Ratio of 4.26, compared to 1734048000 on 8292875. Therefore, it implies a Short% of Shares Outstanding of 8918685 and a Short% of Float of 7.5.
